Patents

Patent Information filled during CTC.

Title Patent Number(s) Assignee Inventor(s)
Animal cloning method, involves transferring somatic cell and/or embryonic cell during induced and/or natural programmed cell death i.e. apoptosis BR200801863-A2 University of São Paulo; FAPESP Bressan FF, Meirelles FV, Merighe GKF, et al.
Human blood coagulation Factor IX recombinant protein, use of a Factor IX  recombinant protein, use of a composition, method of obtaining human blood coagulation Factor IX  recombinant protein and use of the Factor IX  recombinant protein BR 2009/000240 Fundação Hemocentro de Ribeirão Preto and University of São Paulo Covas DT and Fontes AM
Factor VIII human blood coagulation recombinant protein EP 2 180 009 Fundação Hemocentro de Ribeirão Preto and University of São Paulo Covas DT and Fontes AM
Large-scale and stable production of human FVIII in the human cell line Sk-Hep-1 INPI 018110002212 Fundação Hemocentro de Ribeirão Preto and University of São Paulo Covas DT, Picanço-Castro V,

CarbolanteEMSR, Swiech K

Large-scale and stable production of human FVIII in the human cell line Sk-Hep-1 US 8969041 B2 Covas DT, Carbolante EMSR, Picanço-Castro V
Stable and a large-scale production of human FVIII in human cell line Sk-Hep-1 P.I. 11053178 Fundação Hemocentro de Ribeirão Preto and University of São Paulo Covas DT, Carbolante EMSR, Picanço-Castro V
Molecular diagnostic kit for HTLV-½ infection – set of oligonucleotides, method to detect and discriminate HTLV-1/2 targets and kit for diagnosis and discrimination of HTLV-½ infection BR112017 006905-9 Fundação Hemocentro de Ribeirão Preto and University of São Paulo Covas DT,

Rocha-Junior MC,

Kashima,- S

Process of production of blood clotting Factor VII BR 1020150123345 Fundação Hemocentro de Ribeirão Preto and University of São Paulo Covas DT, Freitas, M, Picanço-Castro, V, Swiech, K.
New CAR constructs that modulate IL-15 or IL-27 pathways. Nucleic acid sequence that encodes a natural killer chimeric antigen receptor (NK-CAR), polypeptide of the referred NK-CAR, vector that comprises the referred nucleic acid sequence, in vitro method for obtaining a NK cell, use of the referred sequence, polypeptide or vector, and pharmaceutical composition. BR 10 2022 008333-9 Fundação Hemocentro de Ribeirão Preto Covas DT, Picanço-Castro V, Calado RT, Silvestre, RN
Human recombinant Factor IX variants with increased biological activity and use of them BR 10 2019 007372-1 Fundação Hemocentro de Ribeirão Preto and University of São Paulo Covas DT, Picanço-Castro V,  Bonfim AS, Carbolante EMSR,